True Wealth Design’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$112K Sell
889
-13
-1% -$1.71K 0.03% 227
2026
Q1
$126K Buy
902
+183
+25% +$25.6K 0.03% 165
2025
Q4
$88.3K Sell
719
-8
-1% -$972 0.03% 205
2025
Q3
$80.7K Buy
727
+12
+2% +$1.36K 0.02% 208
2025
Q2
$79.3K Buy
715
+40
+6% +$4.26K 0.03% 135
2025
Q1
$75.7K Buy
675
+69
+11% +$7.12K 0.03% 131
2024
Q4
$56K Sell
606
-29
-5% -$2.61K 0.02% 146
2024
Q3
$53.2K Sell
635
-11,635
-95% -$888K 0.02% 130
2024
Q2
$842K Buy
12,270
+2,013
+20% +$134K 0.21% 68
2024
Q1
$751K Buy
10,257
+825
+9% +$63.4K 0.19% 96
2023
Q4
$764K Buy
9,432
+77
+0.8% +$5.99K 0.22% 88
2023
Q3
$701K Buy
9,355
+32
+0.3% +$2.46K 0.23% 85
2023
Q2
$719K Sell
9,323
-131
-1% -$10.4K 0.26% 91
2023
Q1
$784K Sell
9,454
-1,400
-13% -$116K 0.33% 70
2022
Q4
$932K Buy
+10,854
New +$860K 0.43% 27

Other funds holding GILD

True Wealth Design's GILD Position: Q2 2026 in Review

True Wealth Design reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $1.71K and leaving 889 shares worth $112K. The position accounts for 0.03% of the portfolio, ranked #227.

True Wealth Design first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $932K in Q4 2022. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • True Wealth Design held 889 shares of Gilead Sciences worth $112K as of Q2 2026.
  • True Wealth Design sold 13 Gilead Sciences shares in Q2 2026, an estimated $1.71K.
  • Gilead Sciences made up 0.03% of True Wealth Design's portfolio in Q2 2026, its #227 holding.
  • True Wealth Design first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's Gilead Sciences position peaked at $932K in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.